Difficulty: Medium
Average Score: 78%
Practice
Tick the anticancer alkylating drug, a derivative of chloroethylamine:
Correct answer
C
Rationale
The correct answer is C) Cyclophosphamide. Cyclophosphamide is an anticancer alkylating drug that is a derivative of chloroethylamine. It works by cross-linking DNA strands, leading to cell death. This mechanism makes it effective in inhibiting the growth of cancer cells.
A) Methotrexate is not an alkylating agent but rather an antimetabolite that interferes with the synthesis of DNA and RNA.
B) Cisplatin is a platinum-based chemotherapy drug that forms intrastrand and interstrand cross-links in DNA, but it is not an alkylating agent derived from chloroethylamine.
D) Carmustine is a nitrosourea alkylating agent but not a derivative of chloroethylamine.
Understanding the differences between various classes of anticancer drugs is crucial for healthcare professionals to make informed decisions regarding treatment options for cancer patients. Pharmacology knowledge plays a vital role in selecting appropriate therapeutic interventions, understanding mechanisms of action, and anticipating potential side effects and drug interactions.
A) Methotrexate is not an alkylating agent but rather an antimetabolite that interferes with the synthesis of DNA and RNA.
B) Cisplatin is a platinum-based chemotherapy drug that forms intrastrand and interstrand cross-links in DNA, but it is not an alkylating agent derived from chloroethylamine.
D) Carmustine is a nitrosourea alkylating agent but not a derivative of chloroethylamine.
Understanding the differences between various classes of anticancer drugs is crucial for healthcare professionals to make informed decisions regarding treatment options for cancer patients. Pharmacology knowledge plays a vital role in selecting appropriate therapeutic interventions, understanding mechanisms of action, and anticipating potential side effects and drug interactions.